5436572026-04-012026-06-305436572026-04-012026-06-30in-capmkt:OtherExpenses1Member5436572026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares543657ACINOTLISTEDINE128X01021Archean Chemical Industries LimitedMain BoardEquity2026-04-012027-03-312026-07-302026-07-18INRLakhsQuarterlyFirst quarterSingle segmentMarine Chemicals2026-07-3017:30:002026-07-3019:00:00Not applicablefalsefalseNot Applicable2026-04-012026-06-30UnauditedStandalone315933300016141400033207470003068950000-4986500016203500086388000199150000206299800027676010005531460000553146000170548000-2267900014786900004052770000000405277000-88900040438800024691600023.283.28003.283.28Notes to the unaudited standalone financial results: <br /> 1. Archean Chemical Industries Limited (ACIL or the Company) was incorporated on July 14, 2009. The Company is into manufacturing of Marine Chemicals. The manufacturing location is in Gujarat. <br /> <br /> 2. The above unaudited standalone financial results have been prepared in accordance with the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended and in conformity with Ind AS, as prescribed under Section 133 of Companies Act, 2013 read with relevant rules issued thereunder and accounting principles generally accepted in India. The figures for the quarter ended March 31, 2026 are the balancing figures between audited figures in respect of the full financial year 2025-26 and the published unaudited year to date figures up to the end of the third quarter of that financial year. These unaudited standalone financial results have been reviewed by the Audit Committee and subsequently approved by the Board of Directors in the meeting held on July 30, 2026. These unaudited standalone financial results have been subjected to limited review by the statutory auditors of the Company in accordance with Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 ("the Regulations") who have issued an unmodified conclusion on these unaudited standalone financial results. <br /> <br /> 3. The Company is primarily engaged in the business of manufacture of marine chemicals which is considered as one reportable segment and hence, no additional disclosures with respect to segment information have been made under Ind AS 108 - Operating Segments. <br /> <br /> Due to constarint of space other notes to the unaudited standalone financial results as intimated in the pdf format may be considered. <br /> Other expenses2062998000Remeasurement of defined benefit obligations-1188000-1188000-2990000-889000